Gregory M Marcus

Sep 11, 2024 | healio.com | Scott Buzby |Richard Smith |Gregory M Marcus

You've successfully added Arrhythmia Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: More than 10 million Americans, or nearly 4.5% of the adult U.S. population, may have atrial fibrillation.

Sep 11, 2024 | healio.com | Erik Swain |Richard Smith |Gregory M Marcus

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways:People who quit smoking had less risk for developing atrial fibrillation compared with current smokers. The relationship was true regardless of how long ago participants had quit smoking.

Jun 20, 2024 | jamanetwork.com | Gregory M Marcus |Gregory Curfman |Kirsten Bibbins-Domingo

The First Clinical Test for Calcium Release Deficiency Syndrome? Preliminary Communication A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome Mingke Ni, MD; Ziv Dadon, MD; Julian O. M. Ormerod, MD, PhD; Johan Saenen, MD, PhD; Wiert F. Hoeksema, MD; Pavel Antiperovitch, MD; Rafik Tadros, MD, PhD; Morten K. Christiansen, MD, PhD; Christian Steinberg, MD; Marine Arnaud, MD; Shanshan Tian, PhD; Bo Sun, PhD; John Paul Estillore, MD; Ruiwu Wang, PhD; Habib R.

Feb 7, 2024 | healio.com | Scott Buzby |Richard Smith |Hooman Kamel |Gregory M Marcus

You've successfully added Cardiology: Stroke to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Apixaban did not reduce recurrent stroke risk in patients with atrial cardiopathy without AF. The ARCADIA trial was stopped early for futility.

Feb 7, 2024 | jamanetwork.com | Gregory M Marcus |Bruce Ovbiagele |ARCADIA Investigators

It can be counterintuitive for patients with atrial fibrillation (AF) to understand the evidence-based recommendation to receive anticoagulation therapy despite successful suppression of their arrhythmia with an antiarrhythmic drug.1 After all, the general teaching is that the heightened risk of stroke and systemic thromboemboli occurs due to the stasis of blood in the left atrial appendage produced during rapid and disorganized fibrillation of atrial tissue.